April 11, 2022 06:00 AM EDTUpdated 07:19 AM
People
Startups

Ex­clu­sive: Flag­ship snags an­oth­er CEO-part­ner, on a per­son­al mis­sion, to lead its tR­NA boat

Kyle LaHucik

Senior Reporter

Flag­ship’s All­tr­na bet, an RNA fol­low-up to its sky­rock­et­ing suc­cess with Mod­er­na, has a new face at the helm as of to­day and the nascent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz 

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times